IDEXX Laboratories faces a downturn as investor concerns mount.
IDEXX Laboratories Inc (NASDAQ:IDXX) experienced a notable drop of 1.80% in its stock price today, closing at CA$506.13. The decline comes amidst a backdrop of mixed news regarding the company's recent acquisitions and upcoming earnings report.
Advertisement
IDEXX Laboratories Inc
IDXX.US
IDXX.US
IDEXX Laboratories Inc
WealthAwesomeMarket cap
$40.81B
P/E
36.4x
52W high
$769.98
52W low
$500.61
1W change
-0.08%
Beta
1.55
Analyst Price Targets
Based on 13 analysts covering IDXX · as of Oct 5, 2026
Wall Street analysts forecast IDXX stock price to rise 35.4% over the next 12 months.
Consensus
Buy3.85 / 5.00
Avg. Target
C$701.33
+35.4% Upside
Current Price
C$518.00
Last close
Analyst Breakdown (13 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on IDXX's historical volatility
30-Day Vol
22.4%
Annualized
90-Day Vol
29.0%
Annualized
Trend (90d)
-44.6%
Annualized drift
90d Mean
C$441.68
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$491.20 | C$454.62 – C$530.72 |
| 60 trading days | C$465.78 | C$417.49 – C$519.66 |
| 90 trading days | C$441.68 | C$386.27 – C$505.04 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should be cautious as IDEXX navigates potential challenges ahead, including market reactions to its recent acquisition and upcoming earnings release.
IDEXX's stock down 1.80% today
The company's market cap stands at approximately CA$40.6 billion, highlighting its significant presence in the veterinary healthcare sector.
Bull case
IDEXX's acquisition of CoVetAI could enhance its position in the veterinary diagnostics market by incorporating innovative AI technology. This move aims to improve diagnostic capabilities and streamline operations, which could benefit both the company and its customers.
Bear case
The recent stock drop reflects investor skepticism about the company's growth trajectory and concerns about how economic pressures might affect its operations. Investors are worried that the integration of new technology could pose challenges, impacting IDEXX's performance in the near term.
Advertisement
Market Reaction to Recent Developments
IDEXX's recent acquisition of CoVetAI, a company specializing in AI-driven veterinary solutions, was initially seen as a positive move. However, the market's reaction has been tepid, with investors expressing concerns over the integration of new technology and its potential impact on IDEXX's existing operations.
Upcoming Earnings Report Looms
With the third quarter earnings report set to be released on November 2, 2026, investors are wary of how IDEXX will perform against expectations. The uncertainty surrounding the company's growth prospects, combined with the recent stock decline, suggests that investors are adopting a wait-and-see approach.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
